Suven Pharmaceuticals Ltd.

NSE: SUVENPHAR | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Performer
1135.7000 -1.40 (-0.12%)
NSE May 02, 2025 15:31 PM
Volume: 148.9K
 

1135.70
-0.12%
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE India
With reference to above subject, please find enclosed herewith an invitation for conducting the conference call for investors on today i.e. Monday, December 26, 2022 at 2:30 PM IST to discuss today's announcement that Advent International is to acquire a significant stake in Suven Pharmaceuticals from the Jasti Family. This is for your information and record.
More from Suven Pharmaceuticals Ltd.
All Rapid Results
Recommended